Palmitato isopropilico, minimo 90%, per sintesi, 500 ml, confezione in plastica.

N-Methyl-1-(4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)methanamine hydrochloride, 500mg

4,4,4-Trifluorocrotonitrile, 97.0%, 250mg

(11bR)-N,N-Bis((S)-1-phenylethyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]di-oxaphosphepin-4-amine, 97%, 1g

N-Ethyl-N'-2,2,2-trifluoroethyl ethylenediamine, 96.0%, 1g

1,5-Dichloro-2-fluoro-3-iodobenzene, 97%, 1g

Methyl 4-phenylbutanoate, 95.0%, 25g

tert-butyl 4-(2-ethoxy-2-oxoethyl)-4-fluoropiperidine-1-carboxylate, 95.0%, 500mg

1,6-Diaminohexane>99.0%(GC)(T)25g

3-(4-Methoxyphenyl)thiomorpholine, 95.0%, 250mg

6-tert-Butyl-nicotinonitrile, 95.0%, 5g

5-amino-1,3,6-trimethyl-1,3-dihydro-2H-benzimidazol-2-one hydrochloride, 95.0%, 250mg

1-(6-Hydroxypyridin-3-yl)ethanone, 95.0%, 10g